We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Photonic Scanner Detects Early Signs of Bladder Cancer

By MedImaging International staff writers
Posted on 16 Jul 2020
Print article
Image: A multimodal laser scanner can peer deep into the body (Photo courtesy of TAYS)
Image: A multimodal laser scanner can peer deep into the body (Photo courtesy of TAYS)
A new scanner that uses multi-wavelength lasers can provide detailed information to determine stage and grade of bladder cancer tumors.

The European advanced multimodal photonics laser imaging tool for urothelial diagnosis in endoscopy (AMPLITUDE) scanner project, coordinated by Tampere University Hospital (TAYS; Finland), includes specialists from across the continent, including the Aston Institute of Photonic Technologies (AIPT; United Kingdom), Ampliconyx Oy (Tampere, Finland). The project combines medical and physics expertise to develop a new multi-modal imaging system complete with an endoscopic probe that delivers an instant diagnosis in the clinical setting.

The system works by using infrared (IR) light to visualize deep inside the tissue, allowing scientists to peer into 'biological windows’ where light penetration increases in depth. The multimodal approach (combining confocal and non-linear imaging techniques) is designed to explore the so-called third biological window (1550–1870 nanometer range), that up to now has required a supercontinuum laser source, which is extremely expensive. The lasers that will be developed by AMPLITUDE will use ultrafast fibers at 1700 nm, enhanced by additional output at 850 nm using second harmonic generation from an integrated laser device.

“A societal challenge for the next few decades is the instant diagnosis of major diseases. Photonics provides excellent opportunities to give healthcare professionals advanced, non-invasive diagnostics that detect symptoms and diseases at an early stage,” said Regina Gumenyuk, PhD, project coordinator at TAYS. “This means we can avoid using fluorophores and their phototoxic effects which can sometimes damage cells. A reduction in the phototoxicity during autofluorescence imaging will minimize cell damage.”

Current tests for bladder cancer involve urinalysis, urine cytology, or urine tests for tumor markers, which reflect chromosomal changes in the protein NMP22. While all of these tests can find cancerous cells in the urine, they do not detect the disease in its early stages, and sometimes the tests can miss biomarkers altogether.

Related Links:
Tampere University Hospital
Aston Institute of Photonic Technologies
Ampliconyx Oy


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Brachytherapy Planning System
Oncentra Brachy
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.